Safety of Testosterone Undecanoate i.m. in Hypogonadal Men

This study has been completed.

Study NCT00452322 Information provided by University Hospital Muenster

First Received: March 26, 2007 No Changes Posted

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	January 2007
Estimated Primary Completion Date:	No date given

No publications provided by University Hospital Muenster

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Zitzmann M, Nieschlag E. Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men. J Clin Endocrinol Metab. 2007 Oct;92(10):3844-53. Epub 2007 Jul 17.